Promiscuous Activity of the LXR Antagonist GSK2033 in a Mouse Model of Fatty Liver Disease
Biochemical and Biophysical Research Communications - United States
doi 10.1016/j.bbrc.2016.09.036
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Elsevier BV